Affimed’s AFM13 Data Show Potential Of NK Cell Approach

 
• By Alaric DeArment
  
3d illustration of T cells attacking a cancer cell
Affimed announced interim data from its study of AF13 with pre-complexed NK cells • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer